✦ LIBER ✦

Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinoma

✍ Scribed by Pinto, Álvaro

Book ID: 121560473
Publisher: Springer
Year: 2013
Tongue: English
Weight: 152 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2343-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

973 A NEW STRATEGY FOR CASTRATION RESIST

973 A NEW STRATEGY FOR CASTRATION RESISTANT PROSTATE CANCER WITH TARGETING TO FEEDBACK MECHANISM OF PI3K/AKT/MTOR PATHWAY

✍ Yasumizu, Yota; Miyajima, Akira; Kosaka, Takeo; Miyazaki, Yasumasa; Shirotake, S 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

Is there a need for new agents with nove

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

✍ Orr, C.; Veale, D. J. 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 135 KB

Phase I Safety and Pharmacodynamic of In

Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients

✍ Medioni, J.; Deplanque, G.; Ferrero, J.-M.; Maurina, T.; Rodier, J.-M. P.; Raymo 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 360 KB

S4-04-05: Dimebon: A phase 3 investigati

S4-04-05: Dimebon: A phase 3 investigational agent for Alzheimer's disease with a novel mitochondrial mechanism of action

✍ David Hung 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB